363 related articles for article (PubMed ID: 21092891)
1. Vasoplegia during cardiac surgery: current concepts and management.
Fischer GW; Levin MA
Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
[TBL] [Abstract][Full Text] [Related]
2. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
Gilbert M; Lema G
Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
4. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
Omar S; Zedan A; Nugent K
Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
[TBL] [Abstract][Full Text] [Related]
5. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
7. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
8. Vasoplegic syndrome--the role of methylene blue.
Shanmugam G
Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
[TBL] [Abstract][Full Text] [Related]
9. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.
Levin MA; Lin HM; Castillo JG; Adams DH; Reich DL; Fischer GW
Circulation; 2009 Oct; 120(17):1664-71. PubMed ID: 19822810
[TBL] [Abstract][Full Text] [Related]
10. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
Lavigne D
Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
[TBL] [Abstract][Full Text] [Related]
12. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
[No Abstract] [Full Text] [Related]
14. Does cardiac surgery vasoplegia trigger the postpericardiotomy syndrome?
Edriss H; Lorenzana J; Nugent K
Am J Med Sci; 2015 May; 349(5):463-5. PubMed ID: 25647832
[No Abstract] [Full Text] [Related]
15. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
16. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment and outcomes of vasoplegia after cardiac surgery.
Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response.
Kerbaul F; Collart F; Giorgi R; Ibrahim Z; Guillen JC; Gil JM; Saadjian A; Mouly-Bandini A; Habib G; Gouin F; Guieu R
Crit Care Med; 2006 Mar; 34(3):640-5. PubMed ID: 16505647
[TBL] [Abstract][Full Text] [Related]
19. Vasoplegic syndrome after open heart surgery.
Gomes WJ; Carvalho AC; Palma JH; Teles CA; Branco JN; Silas MG; Buffolo E
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):619-23. PubMed ID: 9833722
[TBL] [Abstract][Full Text] [Related]
20. [Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass].
Lehot JJ
Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S18-21. PubMed ID: 22721515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
